『Episode 46: The Talc Connection』のカバーアート

Episode 46: The Talc Connection

Episode 46: The Talc Connection

無料で聴く

ポッドキャストの詳細を見る

【Amazonプライム会員限定】今ならプレミアムプランが4か月 月額99円。

10月19日まで。※適用条件あり
The most trusted product in the history of the American bathroom — and in some of those bottles, in some of those years, there was asbestos. Episode 46 is the one where the product came home: talc and mesothelioma, the track the press usually blurs with the ovarian-cancer story. The geology is the whole case in one fact — talc and asbestos form in the same rock, and the fiber can't be milled out. The corporate record starts in 1958, thirteen years before the FDA's 1971 "asbestos in talc" conference, where a mineralogist the company hired found asbestos — and was pressed not to publish.Then the series' signature shape: they rigged the ruler and picked the word. The industry's J4-1 testing standard was fifty times less sensitive than the FDA's proposed method, and the trade group voted to call talc "nondetected" instead of "asbestos-free" — an alibi about the microscope dressed as a promise about the powder. The peer-reviewed Moline case series documents 122 confirmed mesotheliomas where cosmetic talc was the only known asbestos exposure — mean latency fifty years, majority women. This is the episode where the victim isn't a boilermaker or a miner; it's a grandmother with no occupational history at all.The litigation is current to October 2026, hedges included. Three "Texas two-step" bankruptcy attempts all failed. In July 2026 the company disclosed in an SEC filing a proposed $5.5 billion resolution of the ovarian-cancer claims — conditional on 95% of claimants signing on — while the mesothelioma cases go one at a time: a $966 million Los Angeles verdict that lost its punitive portion this March, a record $1.56 billion Baltimore verdict now on appeal, and a $45 million verdict upheld on appeal in Illinois. The powder itself is gone — pulled for "misinformation," not safety — and a 2024 consent judgment with 42 states and D.C. means it can never be sold in America again. But the testing floor is still the descendant of the 1977 industry standard, because the FDA withdrew its mandated testing rule in November 2025. And in 2024, FDA sampling found asbestos in a finished baby powder — Dynacare — sold in 35 states and on Amazon. This is not history.What This Episode CoversThe two talc stories — ovarian cancer versus mesothelioma: different mechanisms, different litigation postures, and why this episode keeps the discipline the press drops. Ours is the asbestos track: inhaled fiber, the classic pathway.The roommate in the rock — talc forms in the same rock, through the same process, as asbestos; tremolite, anthophyllite, and chrysotile grow threaded through the ore as accessory minerals that cannot be milled out. A 1968 federal study found fiber in all 22 talcum products tested.Day one — the record starts in 1958 (the Battelle lab's tremolite finding in the supply), runs through the 1971 FDA conference and the Langer suppression, and explains why the cover-up didn't develop over time — it was there from the first year.The rigged ruler and the chosen word — J4-1's 0.5% detection limit versus the FDA's proposed 0.01%; the 1975 vote for "nondetected" over "asbestos-free"; and the 2001 internal email: "Time to come up with more confusion."The science that makes it a lawsuit — the Moline case series: 122 confirmed mesotheliomas, cosmetic talc the only known exposure, ~50-year latency, majority women.The escape hatch that failed — the Texas two-step, three times: two bad-faith dismissals and a rejected plan; then the July 2026 SEC-filed proposal of a conditional $5.5 billion ovarian-claims resolution, with the mesothelioma cases still tried one at a time.Waypoints, not final numbers — the $966M verdict cut to $16M, the record $1.56B verdict on appeal, and the $45M verdict upheld: why headline figures move, in both directions.The floor that never changed — MoCRA ordered a testing rule in 2022; FDA proposed one in December 2024 and withdrew it in November 2025. Plus the 2024 Dynacare recall, the 42-state consent judgment's never-again covenant, and the public evidence ledger behind every claim: asbestosatlas.org/talc.Key Statistics1958 — the earliest dated lab detection in the company's testing record: fibrous tremolite in the talc supply22 of 22, at 8–30% — the 1968 federal study's fiber findings across commercial talcum products0.01% vs 0.5% — the FDA's proposed sensitivity versus the industry standard: fifty times blurrier, chosen on purpose686 of 1,032 — internal talc tests (1948–2017) that detected asbestos, per the peer-reviewed inventory122 cases / ~50-year latency / majority women — the Moline & Golan cosmetic-talc mesothelioma series3 — failed bankruptcy attempts (2021, 2023, 2024)$966M → $16M — the October 2025 Los Angeles verdict after the punitive portion was struck in March 2026$1.56 billion — the record Baltimore verdict (December 22, 2025), on appeal$5.5 billion, conditional — the proposed ovarian-claims resolution disclosed by SEC filing ...
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません